发明名称 |
USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C |
摘要 |
<p>The present invention provides the use of PEG-IFN-alpha conjugates in association with ribavirin for the treatment of chronic hepatitis C infections. The present invention also provides a method for treating chronic hepatitis C infections in patients in need of such treating comprising administering an amount of PEG-IFN-alphaconjugate in association with an amount of ribavirin effective to treat hepatitis C.</p> |
申请公布号 |
SI1087778(T1) |
申请公布日期 |
2006.02.28 |
申请号 |
SI19990030843T |
申请日期 |
1999.05.29 |
申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
ZAHM FRIEDERIKE |
分类号 |
A61K31/70;A61K31/7056;A61K38/21;A61K47/48;A61P1/16;A61P31/12;A61P31/14;A61P43/00 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|